home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Alamo Pharma Services

SHARESHARESHARE
Through outsourced partnerships and internal capabilities, Alamo Pharma Services offers pharmaceutical and biotech companies a viable commercial solution partner to either co-market with existing teams or launch a stand-alone team. Alamo Pharma Services will manage the entire recruiting, hiring, training and ongoing operational support of the sales team. Contact Alamo Pharma Services directly at newbusiness@alamopharmaservices.com.
SHARESHARESHARE

RELATED NEWS


UK-based biopharmaceutical company Mereo BioPharma has announced that its BPS-804 drug has been accepted to participate in the European Medicines Agency’s (EMA) adaptive pathways programme. As part of the adaptive pathways approach, EMA aims to improve timely access for patients to new medicines, primarily in areas of high medical need....

READ MORE

Each year, dozens of branded pharmaceutical products lose their patent protections in a process that routinely paves the way for cheap generics. This year is no different, and the drugs opening up to copycat competitors represent some serious sales heft. And as usual, you'll see some household names at the top of the list of U.S. expirations. What's different these days can be summed up in one word: biosimilars. In the past, patent expirations brought immediate generic competition and th...
FIERCEPHARMA
READ MORE

The US FDA has approved Merck & Co’s Keytruda as an adjuvant treatment for patients with melanoma who have had surgery but still show some evidence of cancer in their lymph nodes. It’s the first time that PD-1 inhibitor Keytruda (pembrolizumab) has been approved in the US for adjuvant use in any cancer, although Merck picked up European approval for this indication in December. Keytruda’s approval in this indication comes on the back of phase III KEYNOTE-054 trial, which sh...

READ MORE

When 2018 began, there was still plenty of uncertainty surrounding the previously untreated lung cancer market—the holy grail for immuno-oncology drugmakers, thanks to its sheer size. Merck had the lead with two approvals for Keytruda, but three other companies were awaiting combo data and aiming to take the crown. Doubts were also swirling among investors that Merck could replicate the phase 2 success for its own combo a Keytruda-chemo pairing in a confirmatory phase 3 study.
Let&r...


READ MORE

Capsugel, a New Jersey-based pharmaceutical supplier, said last week it was being sold to the Swiss manufacturer Lonza for a whopping $5.5 billion. The company's biggest operation in the U.S. is in Greenwood, where it makes and markets medicine capsules that are used by thousands of drug companies. It was last sold in 2011 by Pfizer for about $2.4 billion....
POSTANDCOURIER.COM
READ MORE

Scientists have uncovered a novel antibiotic-free approach that could help prevent and treat one of the most widespread bacterial pathogens, using nanocapsules made of natural ingredients.
Helicobacter pylori (H. pylori) is a bacterial pathogen carried by 4.4 billion people worldwide, with the highest prevalence in Africa, Latin America and the Caribbean. Although the majority of infections show no symptoms, if left untreated the pathogen can cause chronic inflammation of the stomach lini...


READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...